Cargando…
Mechanism of inflammasomes in cancer and targeted therapies
Inflammasomes, composed of the nucleotide-binding oligomerization domain(NOD)-like receptors (NLRs), are immune-functional protein multimers that are closely linked to the host defense mechanism. When NLRs sense pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns...
Autores principales: | Gu, Qingdan, Zou, Jiazhen, Zhou, Ying, Deng, Qiuchan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067570/ https://www.ncbi.nlm.nih.gov/pubmed/37020871 http://dx.doi.org/10.3389/fonc.2023.1133013 |
Ejemplares similares
-
Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway
por: Kuang, Wenbin, et al.
Publicado: (2023) -
The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer
por: Gu, Weigang, et al.
Publicado: (2022) -
Editorial: Targeting cancer cell intracellular metabolism as a strategy against therapy resistance
por: Liu, Lingling, et al.
Publicado: (2023) -
Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy
por: Zou, Yuheng, et al.
Publicado: (2022) -
Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
por: Xue, Yi, et al.
Publicado: (2019)